Viewing Study NCT06041568


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-01 @ 4:13 PM
Study NCT ID: NCT06041568
Status: TERMINATED
Last Update Posted: 2025-02-10
First Post: 2023-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Imvotamab in Severe Systemic Lupus Erythematosus
Sponsor: IGM Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module